A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist’s dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.
It is becoming much more common for patients to be treated with several different medications. It is often necessary for the patient to take them at fixed intervals – a limitation that makes everyday life difficult and increases the risk of doses being skipped or forgotten.
Oliver Lieleg, Professor of Biomechanics and a member of the Munich School of BioEngineering at TUM, and doctoral candidate Ceren Kimna have now developed a process that could serve as the basis for medications containing several active ingredients that would reliably release them in the body in a pre-defined sequence at specified times. “For example, an ointment applied to a surgical incision could release pain medication first, followed by an anti-inflammatory drug and then a drug to reduce swelling,” explains Oliver Lieleg.
One active ingredient after the other
“Ointments or creams releasing their active ingredients with a time delay are not new in themselves,” says Oliver Lieleg. With the drugs currently in use, however, there is no guarantee that two or more active ingredients will not be released into the organism simultaneously.
To test the principle behind their idea, Oliver Lieleg and Ceren Kimna used nanometer-sized silver, iron oxide and gold particles embedded in a special gel-like substance known as a hydrogel. They then used a spectroscopic method to track the exit of the particles from the gel. The particles selected by the researchers have similar motion characteristics within the gel to the particles used to transport real active ingredients, but are easier and cheaper to make.
The special ingredient controlling the nanoparticles is artificial DNA. In nature, DNA is above all the carrier of genetic information. However, researchers are increasingly exploiting another property: The ability of DNA fragments to be combined with great accuracy, both in terms of the types of bonds and their strength, for example to build machines on a nanometer scale.
The DNA cascade: compress and then release at the right instant
The silver particles were released first. In the initial state, the particles were bound together by DNA fragments designed by Lieleg and Kimna using special software. The resulting particle clusters are so large that they are unable to move in the hydrogel. However, when a saline solution is added, they separate from the DNA. They can now move in the gel and drift to the surface. “Because the saline solution has approximately the same salinity as the human body, we were able to simulate conditions where the active ingredients would not be released until the medication is applied,” explains Ceren Kimna.
The mesh-like DNA structure surrounding the iron oxide particles consists of two types of DNA: The first has one end attached to the iron oxide particles. The second type is attached to the loose ends of the first type. These structures are not affected by the saline solution. The iron oxide particles can only be released when the first clusters have dissolved. This event releases not only the silver nanoparticles, but also DNA, which eliminates the “connection DNA” of the second cluster without forming connections itself. As a result, the iron oxide particles can separate. This releases DNA fragments which in turn act as the key to the third DNA-nanoparticle combination.
“The consistency of ointments makes them the most obvious solution for a hydrogel-based approach. However, this principle also has the potential to be used in tablets that could release several effective ingredients in the body in a specific order,” explains Prof. Lieleg.
Learn more: One at a time
The Latest on: Drug delivery
via Google News
The Latest on: Drug delivery
- Connected Drug Delivery Devices Market 2020 Global Trends, Statistics, Size, Share, Regional Analysis By 2025-MRE Reporton January 31, 2020 at 4:19 am
New York, January 31, 2020: Global Connected Drug Delivery Devices Market share consists of several players including F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Ltd., Eli Lilly & Company, Amgen, ...
- 2020 Injectable Drug Delivery Devices Market Report-Size, Growth, Analysis Of Key-players Types And Application, Outlook 2025on January 30, 2020 at 11:23 pm
Injectable Drug Delivery Devices Market Report provides an overview of Injectable Drug Delivery Devices currently in pipeline stage. This report is prepared using data sourced from in-house databases, ...
- Injectable Drug Delivery Market 2026: Global Size, Key Companies, Trends, Growth and Regional Forecasts Researchon January 29, 2020 at 2:12 am
The rising prevalence of chronic diseases such as diabetes, cancer, and others is boosting the global injectable drug delivery market. Fortune Business Insights in a report, titled “INJECTABLE DRUG ...
- IIT Hyderabad develops essential oils-based drug delivery systems to treat fungal infectionson January 28, 2020 at 1:00 am
and CSR grants from AT T, this medication can even counter fungi that have developed resistance to conventional antifungal drugs ...
- Injectable Drug Delivery: A 2-Day Seminar Presented by Experts (London, UK - March 18-19, 2020)on January 27, 2020 at 4:03 pm
DUBLIN, Jan. 27, 2020 /PRNewswire/ -- The "Injectable Drug Delivery" conference has been added to ResearchAndMarkets.com's offering. This seminar has been designed to provide all those working in the ...
- Transdermal and Transmucosal Drug Delivery Systems Market Survey on Growth Strategies 2025: Medipatch, Inc., Aveva Drug Delivery Systemson January 27, 2020 at 10:05 am
Transdermal and transmucosal drug delivery systems as alternative drug delivery routes have gained traction in clinical practices over the past few decades. The need for these systems is driven by the ...
- Using Protein Interaction Networks to Optimize Drug Deliveryon January 27, 2020 at 12:27 am
The benefit of this technique is that the user can quantify in real-time how much of the drug gets to the tumor and the time it remains there ... expert scientific support, and fast international ...
- Nanotechnology Drug Delivery Market Growth Probability, Key Vendors and Future Scenario Up to 2023on January 24, 2020 at 8:30 am
Albany, NY -- (SBWIRE) -- 01/24/2020 -- The competitive landscape of the global nanotechnology drug delivery market is largely consolidated, with a small number of companies accounting for dominant ...
- European Diabetes Market Report 2019 to 2025 - Covering Diabetes Monitoring, Treatment & Drug Delivery - ResearchAndMarkets.comon January 24, 2020 at 8:14 am
This report covers the European market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), ...
- Two new FDA-approved products simplify drug delivery after cataract surgeryon January 20, 2020 at 5:31 pm
by Alaina Tedesco Reference: Hovanesian JA. Drug delivery in cataract surgery. Presented at: Hawaiian Eye 2020; Jan. 18-24, 2020; Koloa, Hawaii. Disclosure: Hovanesian reports financial ties to ...
via Bing News